ADMA Biologics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
421.67 |
502.07 |
625.43 |
822.97 |
972.40 |
1,097.77 |
| Przychód Δ r/r |
0.00% |
19.07% |
24.57% |
31.58% |
18.16% |
12.89% |
| Przychód (min) |
420.20 |
500.32 |
621.72 |
810.97 |
969.01 |
1,093.94 |
| Przychód (max) |
424.09 |
504.95 |
633.38 |
834.96 |
977.99 |
1,104.08 |
| EBITDA (średnia) |
-130.77 |
-155.70 |
-193.96 |
-255.22 |
-301.56 |
-340.44 |
| EBIT (średnia) |
-144.70 |
-172.29 |
-214.62 |
-282.40 |
-333.68 |
-376.70 |
| EBIT % |
-34.32% |
-34.32% |
-34.32% |
-34.32% |
-34.32% |
-34.32% |
| Zysk netto (średni) |
206.77 |
148.44 |
225.50 |
301.98 |
395.84 |
468.03 |
| Zysk netto % |
49.04% |
29.57% |
36.05% |
36.69% |
40.71% |
42.63% |
| EPS (średnia) |
0.51 |
0.61 |
0.93 |
1.31 |
1.63 |
1.92 |
| Liczba analityków (Przychody) |
3 |
2 |
4 |
4 |
2 |
3 |
| Liczba analityków (EPS) |
3 |
2 |
2 |
4 |
3 |
2 |
| symbol |
ADMA |
ADMA |
ADMA |
ADMA |
ADMA |
ADMA |